- Title
- Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19
- Creators
- B Joseph Elmunzer - Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, South Carolina. Electronic address: elmunzer@musc.eduBethany J Wolf - Department of Public Health Sciences, Medical University of South Carolina, Charleston, South CarolinaJames M Scheiman - Division of Gastroenterology, University of Virginia Medical School, Charlottesville, VirginiaWilliam M Tierney - Section of Digestive Diseases and Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City, OklahomaJason R Taylor - Division of Gastroenterology and Hepatology, Saint Louis University, St. Louis, MissouriNorth American Alliance for the Study of Digestive Manifestations of COVID-19
- Publication Details
- Gastroenterology (New York, N.Y. 1943), Vol.160(4), pp.1417-1422.e14
- Grant note
- P30 DK123704 / NIDDK NIH HHS
- Language
- English
- Resource Type
- Journal article
- PMID
- 33189702
- Record Identifier
- 991031614753302976
Journal article
Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19
Gastroenterology (New York, N.Y. 1943), Vol.160(4), pp.1417-1422.e14
2021-03
PMID: 33189702
Metrics
6 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.104 Virology - General
- 1.104.1353 Coronavirus
- Web Of Science research areas
- Gastroenterology & Hepatology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites